The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of dipeptidyl protease 4 (DPP4) inhibitors on progression-free survival in patients with metastatic renal cell carcinoma: A single-center retrospective analysis.
 
Soham Ali
No Relationships to Disclose
 
Kathryn Fortune
No Relationships to Disclose
 
Jack Masur
No Relationships to Disclose
 
Paul Vincent Viscuse
No Relationships to Disclose
 
Michael Edward Devitt
Consulting or Advisory Role - Astellas Pharma; Seagen
Research Funding - Arvinas (Inst); Kangpu Biopharmaceuticals (Inst); Propella Therapeutics (Inst); Propella Therapeutics (Inst); Seagen (Inst); Syneos Health (Inst); Veru (Inst)
 
Robert Dreicer
Consulting or Advisory Role - Astellas Pharma; AVEO; Bayer; Gilead Sciences; Hinova Pharmaceuticals; Janssen Oncology; Merck; Pfizer; Seagen; Tavanta Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Seagen (Inst)
 
William Paul Skelton
No Relationships to Disclose